Upgrade to SI Premium - Free Trial

Immuneering Corporation (IMRX) PT Lowered to $1.50 at Jefferies

May 8, 2024 7:39 AM
Jefferies analyst Michael Yee lowered the price target on Immuneering Corporation (NASDAQ: IMRX) to $1.50 (from $3.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles